Abstract
Background Reported transmission rates of SARS-CoV-2 within families vary widely, and there are few reports on transmission from children to other family members. More knowledge is needed to guide infection control measures.
Objective To characterize the family index case for detected SARS-CoV-2 and describe testing and secondary attack rates in the family.
Design Register-based cohort study.
Setting Individual-level administrative data of all families and all PCR tests for SARS-CoV-2 in Norway in 2020.
Participants All families with at least one parent and one child below the age of 20, who lived at the same address (N=662 582), where at least one member tested positive for SARS-CoV-2 in 2020.
Main outcome measures Secondary attack rates (SAR7) were defined as the share of non-index family members with a positive PCR test within seven days of the index case. SARs were calculated separately for parent- and child-index cases, and for parent- and child-secondary cases.
Results We identified 7548 index cases, comprising 26 991 individuals, of which 12184 were parents and 14808 children. The index was a parent in 66% of the cases. Among the children, 42% of the index cases were in the age group 17-20 and only 8% 0-6 years. When the index was a parent, SAR7 was 24% (95%CI 24 to 25), whilst SAR7 was 14% (95%CI 13 to 15) when the index was a child. However, SAR7 was 24% (95%CI 20 to 28) when the index was a child aged 0-6 years and declined steeply with increasing age of the index child. SAR7 from index parent to other parents was 35% (95%CI 33 to 36), and from index child to other children 12% (95%CI 11 to 13). SAR7 from index child aged 0-6 to parents was 27% (95%CI 22 to 33). The percent of non-index family members tested within 7 days after the index case, increased from about 20% in April to 80% in December, however, SAR7 stabilized at about 20% from May.
Conclusion Parents and older children are most often index cases for SARS-CoV-2 in families in Norway, while parents and young children more often transmit the virus within the families. This study suggests that whilst the absolute infection numbers are low for young children because of their low introduction rate, when infected, young children and parents transmit the virus to the same extent within the family.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by the Norwegian Institute of Public Health. No external funding was received. The funding sources had no influence on the design or conduct of the study, the collection, management, analysis, or interpretation of the data, the preparation, review, or approval of the manuscript, or the decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional board review was conducted, and the Ethics Committee of South-East Norway confirmed (June 4th 2020, #153204) that an external ethical board review was not required. From our ethics comittee application: Knowledge of transmission, health service use and hospitalization for different geographic groups (e.g. municipality), in particular health personell, teachers and child care workers, waiters, taxi drviers etc is crucial for the emergency preparedness nationally and locally. Of particular importance are occupational risks for health personnel and others working in the health services, and how the authorities' measures to limit transmission (school lock downs, restrictions on travel, social distancing etc) impacts transmission to e.g. teachers, child care workers, hair dressers, taxi drviers etc. Further, it is important to study other sociodemographic factors of whom are being tested (age, sex, geography, etc.) and whom are testing positive (virus and antibodies), as well as how the testing and the results are within families.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The applied registry data contain sensitive information at the individual level and access are strictly regulated by Norwegian law.
https://www.fhi.no/sv/smittsomme-sykdommer/corona/norsk-beredskapsregister-for-covid-19/
